FDA recall D-064-2013

GlaxoSmithKline, LLC. · Class III · drug

Product

Advair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 Metered Actuations, For Oral Inhalation with Advair HFA actuator only, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0715-20.

Reason for recall

Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.

Distribution

Nationwide and Puerto Rico.

Key facts

Status
Terminated
Initiation date
2012-10-24
Report date
2012-12-05
Termination date
2014-09-11
Voluntary/Mandated
Voluntary: Firm initiated
Location
Zebulon, NC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-064-2013